Pulmonary tumor embolism in renal cell carcinoma detected by hybrid CT and F18-PSMA PET

Pulmonary tumor embolism in renal cell carcinoma detected by hybrid CT and F18-PSMA PET

We present the case of a 75-year-old female in which a pulmonary tumor embolism was detected incidentally on a prostate-specific membrane antigen positron emission tomography-computed tomography restaging scan. This occurred on the background of renal cell carcinoma in remission with pazopanib syste...

Full description

Bibliographic Details
Main Authors:	Jared E. Tan, B-BMED, Sai Vishnu, Dalveer Singh, MBBS, FRANZCR
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Radiology Case Reports
Subjects:	Pulmonary tumor embolism Renal cell carcinoma PSMA PET/CT
Online Access:	http://www.sciencedirect.com/science/article/pii/S1930043323006088

Similar Items

18F DCFPyL PSMA avid biopsy proven subcutaneous capillary haemangioma as a malignancy mimic in the setting of biochemical recurrent prostate carcinoma
by: Manvinder Dhillon, MBBS, BMedSci, PGDAAD, MS, et al.
Published: (2022-06-01)

Dose-reduced [18F]PSMA-1007 PET is feasible for functional imaging of the renal cortex
by: Kristian Valind, et al.
Published: (2021-10-01)

PSMA-PET/CT in Patients with Recurrent Clear Cell Renal Cell Carcinoma: Histopathological Correlations of Imaging Findings
by: Falk Gühne, et al.
Published: (2021-06-01)

PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature
by: Stijn Muselaers, et al.
Published: (2022-03-01)

High Prognostic Value of <sup>68</sup>Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry
by: Donatello Gasparro, et al.
Published: (2023-09-01)

Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on <sup>18</sup>F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression
by: Lena M. Mittlmeier, et al.
Published: (2021-03-01)

PSMA-Positive Low Malignant Gastrointestinal Stromal Tumor in the Stomach on F-18-PSMA-1007 PET/CT
by: Peter Iversen, et al.
Published: (2022-01-01)

Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients
by: Leon Will, et al.
Published: (2017-12-01)

The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer—A Practical Clinical Review
by: Anna Rebecca Lisney, et al.
Published: (2022-07-01)

68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
by: Amir Iravani, et al.
Published: (2017-12-01)

The Impact of PSMA PET/CT on Modern Prostate Cancer Management and Decision Making—The Urological Perspective
by: Azik Hoffman, et al.
Published: (2023-06-01)

Plug inguinal hernia repair mimicking nodal spread of prostate cancer on PSMA-PET/CT
by: Genevieve C. Muñoz, MA, et al.
Published: (2023-01-01)

The Value of <sup>68</sup>Ga-PSMA PET/CT Following Equivocal <sup>18</sup>F-NaF PET/CT in Prostate Cancer Patients
by: Claus Madsen, et al.
Published: (2020-05-01)

PSMA-Positive Follicular Thyroid Carcinoma Incidentally Detected by [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT: Correlation with Immunohistology Confirms Neovascular PSMA-Expression
by: Florian Rosar, et al.
Published: (2022-05-01)

Intra-patient comparison of physiologic 68Ga-PSMA-11 and 18F-DCFPyL PET/CT uptake in ganglia in prostate cancer patients: a pictorial essay
by: Medhat M. Osman, et al.
Published: (2021-04-01)

Evaluating the biodistribution for [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET/CT with an inter- and intrapatient based analysis
by: Cristina E. Popescu, et al.
Published: (2024-04-01)

(18F)-PSMA-1007PET/CT in patients with biochemical recurrence after radical prostatectomy: Diagnostic performance and impact on treatment management
by: Jia Jiang, et al.
Published: (2023-03-01)

[18F]PSMA-1007 PET is comparable to [99mTc]Tc-DMSA SPECT for renal cortical imaging
by: Kristian Valind, et al.
Published: (2023-11-01)

Concomitant Prostate Cancer and Hodgkin Lymphoma: A Differential Diagnosis Guided by a Combined 68Ga-PSMA-11 and 18F-FDG PET/CT Approach
by: Alberto Miceli, et al.
Published: (2021-09-01)

Head-to-Head Comparison of [<sup>18</sup>F]PSMA-1007 and [<sup>18</sup>F]FDG PET/CT in Patients with Triple-Negative Breast Cancer
by: Natalia Andryszak, et al.
Published: (2024-02-01)

Active Lumbar Spondylodiscitis on [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT Mimicking Bone Metastasis
by: Florian Rosar, et al.
Published: (2023-12-01)

Advanced PSMA-PET/CT Imaging Parameters in Newly Diagnosed Prostate Cancer Patients for Predicting Metastatic Disease
by: Yaniv Yechiel, et al.
Published: (2023-02-01)

Incidental prostate-specific membrane antigen-avid glioblastoma detected on 68Ga–prostate-specific membrane antigen PET/CT
by: James Yuheng Jiang, MD, MMed, et al.
Published: (2022-06-01)

Histologically Confirmed Testicular Metastasis Revealed by [<sup>89</sup>Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging
by: Florian Rosar, et al.
Published: (2023-04-01)

A single centre pilot experience with 18F-JK-PSMA-7 PET-CT in the staging of prostate cancer
by: Szigeti András, et al.
Published: (2022-02-01)

Ductal prostate cancer staging: Role of PSMA PET/CT
by: Pietro Pepe, et al.
Published: (2024-02-01)

18F-DCFPyL PET/CT in Newly Diagnosed Prostate Cancer: Diagnostic Value of Intraprostatic PSMA Uptake in Risk Classification of Prostate Cancer
by: Shuoming Zhou, et al.
Published: (2022-02-01)

PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
by: Alexander D. Combes, et al.
Published: (2022-10-01)

Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with <sup>68</sup>Ga-PSMA PET/CT Features in Primary Staging
by: Luigia Vetrone, et al.
Published: (2023-03-01)

Comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer: a protocol for systematic review and meta-analysis
by: Garba Haruna Yunusa, et al.
Published: (2021-07-01)

Optimization of [18F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer
by: Elin Trägårdh, et al.
Published: (2020-05-01)

Prostate cancer brain metastases: Monitoring response to treatment with PSMA PET/CT
by: Anas Al-Zubaidi, MD, et al.
Published: (2024-06-01)

Detection of a Meckel's diverticulum on PSMA PET/CT: A case report
by: Mitchell M. Huang, et al.
Published: (2020-11-01)

PET/CT imaging 2 h after injection of [18F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h
by: Erland Hvittfeldt, et al.
Published: (2023-05-01)

Tubarial salivary glands on PSMA ligands based PET imaging and post 177Lu PSMA therapy scan: reiterating its importance
by: Srinivas Kumar, et al.
Published: (2024-01-01)

A Prospective Study on [68Ga]-PSMA PET/CT Imaging in Newly Diagnosed Intermediate- and High-Risk Prostate Cancer
by: Sara Harsini, et al.
Published: (2021-07-01)

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer
by: Sarah Piron, et al.
Published: (2020-02-01)

A pilot study of 68 Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma
by: Guochang Wang, et al.
Published: (2022-08-01)

The performance of 18F-PSMA PET/CT in the detection of prostate cancer: a systematic review and meta-analysis
by: Zhi-Qiang Qin, et al.
Published: (2022-01-01)

Aberrant right gastric vein mimicking hepatic spread of prostate cancer on PSMA-PET/CT
by: Genevieve C. Muñoz, MA, et al.
Published: (2023-03-01)